Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study

Authors: Paolo Giorgi Rossi, Simonetta Bisanzi, Irene Paganini, Angela Di Iasi, Claudio Angeloni, Aurora Scalisi, Rosalba Macis, Maria Teresa Pini, Francesco Chini, Francesca Maria Carozzi, HPV Prevalence Italian Working Group

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

This multicenter study describes the type-specific prevalence of HPV infection in the general population from central and southern Italy, comparing the data with previously published Italian studies.

Methods

Women aged from 25 to 65 who attended cervical cancer screening in five different Italian regions were tested for HPV infection with Hybrid Capture II (HCII) low and high risk probes. Women repeating Pap-test upon unsatisfactory or positive results, or as a post-treatment and post-colposcopy follow-up analysis, were excluded from our study. High risk (HR) HPV positive samples were typed using GP5+/GP6+ primed PCR, followed by Reverse Line Blot for 18 high/intermediate risk HPV types, while low risk (LR) HPV positive samples were tested with type specific primers for HPV6 and HPV11.

Results

3817 women had a valid HCII test: 350 of them (9.2%) were positive for HR probes, 160 (4.2%) for LR probes, while 57 women were positive for both. Multiple infections were detected in 97 HR HPV positive women. The most common types were HPV 16 (3%), 31 (1.2%), 51 (1%). HPV6 ranked fifth (0.6%), HPV18 ranked tenth (0.5%) and HPV11 sixteenth (0.3%).
In Sardinia the prevalence of high-risk infection was 13%, significantly higher than the mean value (p < 0.00005).
The distribution of the most frequent types did not significantly differ by centre (p = 0.187) and age (p = 0.085).

Conclusions

Because cervical cancer incidence and Pap test coverage is lower in southern than in northern Italy, a lower prevalence of high-risk infections in the general population was expected in the south. However, prevalence detected in this study for the south of the country is slightly but significantly higher than the rest of Italy. The consequence may be an epidemic of cervical cancer in the next decades if adequate screening programs are not implemented there.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-9. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-9. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed
2.
go back to reference Intesa del 20 dicembre 2007 tra il Ministero della Salute le Regioni e le Province Autonome di Trento e Bolzano. "Strategia per l'offerta attiva del vaccino contro l'infezione da HPV in Italia". Intesa del 20 dicembre 2007 tra il Ministero della Salute le Regioni e le Province Autonome di Trento e Bolzano. "Strategia per l'offerta attiva del vaccino contro l'infezione da HPV in Italia".
3.
go back to reference Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J: New Technologies for Cervical Cancer Working Group. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006, 98: 765-74. 10.1093/jnci/djj209.CrossRefPubMed Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J: New Technologies for Cervical Cancer Working Group. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006, 98: 765-74. 10.1093/jnci/djj209.CrossRefPubMed
4.
go back to reference Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J: New Technologies for Cervical Cancer screening Working Group. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 2006, 7: 547-55. 10.1016/S1470-2045(06)70731-8.CrossRefPubMed Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J: New Technologies for Cervical Cancer screening Working Group. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 2006, 7: 547-55. 10.1016/S1470-2045(06)70731-8.CrossRefPubMed
5.
go back to reference Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N: New Technologies for Cervical Cancer Screening Working Group. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008, 100: 492-501. 10.1093/jnci/djn065. Epub 2008 Mar 25CrossRefPubMed Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N: New Technologies for Cervical Cancer Screening Working Group. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008, 100: 492-501. 10.1093/jnci/djn065. Epub 2008 Mar 25CrossRefPubMed
6.
go back to reference Centurioni MG, Puppo A, Merlo DF, Pasciucco G, Cusimano ER, Sirito R, Gustavino CA: Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis. 2005, 5: 77-10.1186/1471-2334-5-77.CrossRefPubMedPubMedCentral Centurioni MG, Puppo A, Merlo DF, Pasciucco G, Cusimano ER, Sirito R, Gustavino CA: Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis. 2005, 5: 77-10.1186/1471-2334-5-77.CrossRefPubMedPubMedCentral
7.
go back to reference Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, Buonaguro L, Buonaguro FM: Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol. 2008, 89: 1380-9. 10.1099/vir.0.83553-0.CrossRefPubMed Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, Buonaguro L, Buonaguro FM: Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol. 2008, 89: 1380-9. 10.1099/vir.0.83553-0.CrossRefPubMed
8.
go back to reference Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S: Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005, 41: 297-305. 10.1016/j.ejca.2004.07.005.CrossRefPubMed Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S: Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005, 41: 297-305. 10.1016/j.ejca.2004.07.005.CrossRefPubMed
9.
go back to reference Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A: Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev. 2008, 17: 2002-6. 10.1158/1055-9965.EPI-08-0180.CrossRefPubMed Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A: Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev. 2008, 17: 2002-6. 10.1158/1055-9965.EPI-08-0180.CrossRefPubMed
11.
go back to reference ISTAT - Unit Struttura e dinamica sociale. Health interview survey: Health status and use of health services - Years 2004-2005. 2006, ISTAT Roma ISTAT - Unit Struttura e dinamica sociale. Health interview survey: Health status and use of health services - Years 2004-2005. 2006, ISTAT Roma
12.
go back to reference Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A, Dalla Palma P, Zanier L, Barca A, Gaimo MD, Maglietta R, Mancini E, Pizzuti R, Iossa A, Segnan N, Zappa M: Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity. Epidemiol Prev. 2009, 33 (3 Suppl 2): 41-56.PubMed Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A, Dalla Palma P, Zanier L, Barca A, Gaimo MD, Maglietta R, Mancini E, Pizzuti R, Iossa A, Segnan N, Zappa M: Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity. Epidemiol Prev. 2009, 33 (3 Suppl 2): 41-56.PubMed
13.
go back to reference von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P: Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening. First Report. 2008, City of Luxembourg, Grand Duchy of Luxembourg: Services of the European Commission von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P: Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening. First Report. 2008, City of Luxembourg, Grand Duchy of Luxembourg: Services of the European Commission
14.
go back to reference European Commission: Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions. Implementation of the Council Recommendation of 2 December 2003 on Cancer Screening (2003/878/EC). 2008, Brussels, Belgium: Commission of the European Communities, 22.12.2008. COM 2008; 882 final European Commission: Report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions. Implementation of the Council Recommendation of 2 December 2003 on Cancer Screening (2003/878/EC). 2008, Brussels, Belgium: Commission of the European Communities, 22.12.2008. COM 2008; 882 final
15.
go back to reference Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6: 204-10.1016/S1470-2045(05)70086-3.CrossRefPubMed Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6: 204-10.1016/S1470-2045(05)70086-3.CrossRefPubMed
16.
go back to reference Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-27. 10.1056/NEJMoa021641.CrossRefPubMed Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-27. 10.1056/NEJMoa021641.CrossRefPubMed
17.
go back to reference Arbyn M, Dillner J: Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol. 2007, 38: 189-97. 10.1016/j.jcv.2006.12.009.CrossRefPubMed Arbyn M, Dillner J: Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol. 2007, 38: 189-97. 10.1016/j.jcv.2006.12.009.CrossRefPubMed
18.
go back to reference Carozzi FM, Del Mistro A, Confortini M, Sani C, Puliti D, Trevisan R, De Marco L, Tos AG, Girlando S, Palma PD, Pellegrini A, Schiboni ML, Crucitti P, Pierotti P, Vignato A, Ronco G: Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol. 2005, 124: 716-21. 10.1309/84E5WHJQHK83BGQD.CrossRefPubMed Carozzi FM, Del Mistro A, Confortini M, Sani C, Puliti D, Trevisan R, De Marco L, Tos AG, Girlando S, Palma PD, Pellegrini A, Schiboni ML, Crucitti P, Pierotti P, Vignato A, Ronco G: Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol. 2005, 124: 716-21. 10.1309/84E5WHJQHK83BGQD.CrossRefPubMed
19.
go back to reference Van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ: GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol. 2002, 40: 779-87. 10.1128/JCM.40.3.779-787.2002.CrossRefPubMed Van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ: GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol. 2002, 40: 779-87. 10.1128/JCM.40.3.779-787.2002.CrossRefPubMed
20.
go back to reference Bauer HM, Greer CE, Manos MM: Determination of genital human papillomavirus infection using consensus PCR. Diagnostic molecular pathology: a practical approach. Edited by: Herrington CS, McGee JOD. 1992, Oxford University Press, Oxford, United Kingdom, 132-152. Bauer HM, Greer CE, Manos MM: Determination of genital human papillomavirus infection using consensus PCR. Diagnostic molecular pathology: a practical approach. Edited by: Herrington CS, McGee JOD. 1992, Oxford University Press, Oxford, United Kingdom, 132-152.
21.
go back to reference Walboomers JMM, Melkert PWJ, Van Den Brule AJC, Snijders PJF, Meijer CJLM: The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. A practical approach. Edited by: Herrington CS, McGee JOD. 1992, Oxford University Press, Oxford, United Kingdom Walboomers JMM, Melkert PWJ, Van Den Brule AJC, Snijders PJF, Meijer CJLM: The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. A practical approach. Edited by: Herrington CS, McGee JOD. 1992, Oxford University Press, Oxford, United Kingdom
22.
go back to reference Stata Statistical Software: Release 8.0 College Station. TX: Stata Corporation Stata Statistical Software: Release 8.0 College Station. TX: Stata Corporation
23.
go back to reference Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A: Restricted Cross-Reactivity of Hybrid Capture 2 with Nononcogenic Human Papillomavirus Types. Cancer Epidemiol Biomark Prev. 2002, 11: 1394-9. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A: Restricted Cross-Reactivity of Hybrid Capture 2 with Nononcogenic Human Papillomavirus Types. Cancer Epidemiol Biomark Prev. 2002, 11: 1394-9.
24.
go back to reference Astori G, Arzese A, Pipan C, de Villiers EM, Botta GA: Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res. 1997, 50: 57-63. 10.1016/S0168-1702(97)00054-3.CrossRefPubMed Astori G, Arzese A, Pipan C, de Villiers EM, Botta GA: Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res. 1997, 50: 57-63. 10.1016/S0168-1702(97)00054-3.CrossRefPubMed
25.
go back to reference Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM, Italian HPV Working Group: Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol. 2006, 78: 1663-72. 10.1002/jmv.20752.CrossRefPubMed Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM, Italian HPV Working Group: Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol. 2006, 78: 1663-72. 10.1002/jmv.20752.CrossRefPubMed
26.
go back to reference Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM: Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer. 2007, 2: 1-10.1186/1750-9378-2-1.CrossRefPubMedPubMedCentral Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM: Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer. 2007, 2: 1-10.1186/1750-9378-2-1.CrossRefPubMedPubMedCentral
27.
go back to reference Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R, Miragliotta G: Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol. 2008, 42: 211-4. 10.1016/j.jcv.2008.01.011. Epub 2008 Mar 14CrossRefPubMed Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R, Miragliotta G: Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol. 2008, 42: 211-4. 10.1016/j.jcv.2008.01.011. Epub 2008 Mar 14CrossRefPubMed
28.
go back to reference Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L: Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol. 2009, 81: 529-35. 10.1002/jmv.21347.CrossRefPubMed Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L: Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol. 2009, 81: 529-35. 10.1002/jmv.21347.CrossRefPubMed
29.
go back to reference Giovannelli L, Vassallo R, Matranga D, Affronti M, Caleca MP, Bellavia C, Perino A, Ammatuna P: Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy. Acta Obstet Gynecol Scand. 2009, 88: 737-42. 10.1080/00016340902952318.CrossRefPubMed Giovannelli L, Vassallo R, Matranga D, Affronti M, Caleca MP, Bellavia C, Perino A, Ammatuna P: Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy. Acta Obstet Gynecol Scand. 2009, 88: 737-42. 10.1080/00016340902952318.CrossRefPubMed
30.
go back to reference Masia G, Mazzoleni AP, Contu G, Laconi S, Minerba L, Montixi S, Montis F, Onano A, Porcedda E, Coppola RC: Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Vaccine. 2009, 27 (Suppl 1): A11-6. 10.1016/j.vaccine.2008.10.095.CrossRefPubMed Masia G, Mazzoleni AP, Contu G, Laconi S, Minerba L, Montixi S, Montis F, Onano A, Porcedda E, Coppola RC: Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Vaccine. 2009, 27 (Suppl 1): A11-6. 10.1016/j.vaccine.2008.10.095.CrossRefPubMed
31.
go back to reference Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, Nicosia R, Chiarini F, Antonelli G, Degener AM: Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis. 2009, 9: 16-10.1186/1471-2334-9-16.CrossRefPubMedPubMedCentral Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, Nicosia R, Chiarini F, Antonelli G, Degener AM: Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis. 2009, 9: 16-10.1186/1471-2334-9-16.CrossRefPubMedPubMedCentral
32.
go back to reference De Angelis R, Rossi S, Martina L: Gruppo di lavoro AIRTUM and Capocaccia R. Stima di incidenza e mortalità per cervico-carcinoma (CC) in Italia. Rapporto Istisan, ISS, Roma. De Angelis R, Rossi S, Martina L: Gruppo di lavoro AIRTUM and Capocaccia R. Stima di incidenza e mortalità per cervico-carcinoma (CC) in Italia. Rapporto Istisan, ISS, Roma.
34.
go back to reference Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006, 119: 2677-84. 10.1002/ijc.22241.CrossRefPubMed Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006, 119: 2677-84. 10.1002/ijc.22241.CrossRefPubMed
35.
go back to reference Deiana L, Ferrucci L, Pes GM, Carru C, Delitala G, Ganau A, Mariotti S, Nieddu A, Pettinato S, Putzu P, Franceschi C, Baggio G: AKEntAnnos. The Sardinia Study of Extreme Longevity. Aging (Milano). 1999, 11 (3): 142-9. Deiana L, Ferrucci L, Pes GM, Carru C, Delitala G, Ganau A, Mariotti S, Nieddu A, Pettinato S, Putzu P, Franceschi C, Baggio G: AKEntAnnos. The Sardinia Study of Extreme Longevity. Aging (Milano). 1999, 11 (3): 142-9.
36.
go back to reference Ronco G, Segnan N, Giordano L, Pilutti S, Senore C, Ponti A, Volante R: Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer. 1997, 33: 1262-7. 10.1016/S0959-8049(97)00076-2.CrossRefPubMed Ronco G, Segnan N, Giordano L, Pilutti S, Senore C, Ponti A, Volante R: Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer. 1997, 33: 1262-7. 10.1016/S0959-8049(97)00076-2.CrossRefPubMed
37.
go back to reference Giorgi Rossi P, Esposito G, Brezzi S, Brachini A, Raggi P, Federici A: Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Serv Res. 2006, 6: 36-10.1186/1472-6963-6-36.CrossRefPubMedPubMedCentral Giorgi Rossi P, Esposito G, Brezzi S, Brachini A, Raggi P, Federici A: Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Serv Res. 2006, 6: 36-10.1186/1472-6963-6-36.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study
Authors
Paolo Giorgi Rossi
Simonetta Bisanzi
Irene Paganini
Angela Di Iasi
Claudio Angeloni
Aurora Scalisi
Rosalba Macis
Maria Teresa Pini
Francesco Chini
Francesca Maria Carozzi
HPV Prevalence Italian Working Group
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-214

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue